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Abstract
Background: A clinical history of peptic ulcer has been reported to be associated with a high rate of ulcer
recurrence in nonsteroidal anti-inflammatory drug (NSAID) users. Therefore, it is a very important issue to precisely
know the previous history prior to NSAIDs administration. To clarify the possible difficulty to identify the history, we
determined the sensitivity and diagnostic concordance of endoscopy for the identification of ulcer scars indicative
of previous clinical history of peptic ulcer diseases.
Methods: The first study enrolled 200 consecutive patients with a clinical history of gastric or duodenal ulcers
previously confirmed by esophagogastroduodenoscopy. The sensitivity of endoscopy for identifying scars was
determined for these patients. In the second study, the extent of interobserver agreement was determined for 47
endoscopists who identified ulcer scars in endoscopic photographs of 30 sites of previous active gastric ulcers and
30 sites of previous active duodenal ulcers. The kappa coefficient of reliability was calculated to measure the
interobserver agreement on the diagnosis of ulcer scars.
Results: Out of 190 patients eligible for analysis, 104 (54.7%) were found to have gastric or duodenal ulcer scars on
endoscopy; there were no gastric or duodenal ulcer scars seen in the remaining patients (45%). In the second
study, the kappa values for endoscopic diagnosis of gastric and duodenal ulcer scars were 0.14 (95% CI 0.13-0.16)
and 0.29 (95% CI 0.27-0.32), respectively. The addition of indigo-carmine chromoendoscopy did not provide a
statistically significant improvement in diagnostic concordance in patients with gastric ulcer scar since the kappa
value for chromoendoscopic diagnosis was 0.15; 95% CI 0.13-0.17 as low as for un-contrasted scars.
Conclusions: The sensitivity and concordance of endoscopic diagnosis of gastric and duodenal ulcer scars are not
satisfactory for the use of endoscopy only to identify previous ulcer disease. To avoid the overlooking the previous
clinical history of peptic ulcer diseases, the diagnosis of peptic ulcer scar has to be carefully done prior to NSAIDs
administration.
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Background
Nonsteroidal anti-inflammatory drugs (NSAIDs) are
widely prescribed and have become increasingly asso-
ciated with adverse gastroduodenal events [1,2]. Gastric
and duodenal ulcers have been reported to be found in
as high as 17% of chronic NSAIDs users and 12% of
low-dose aspirin (LDA) users. Coadministration of pro-
ton pump inhibitors (PPIs) reduces the proportion of
gastric and duodenal complications associated with
NSAIDs and LDA [3,4]. It has been recommended that
PPIs should be coadministered with NSAIDs and LDA
in patients with clinical characteristics associated with
high risk for ulcer development, including old age, past
history of peptic ulcer or complications, and concomi-
tant use of aspirin, anticoagulants, and/or antiplatelet
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any medium, provided the original work is properly cited.agents [5-11]. A past history of peptic ulcer is reported
to be the factor most strongly associated with ulcer
development [12,13]. Therefore, NSAIDs or LDA users
with a past history of gastric or duodenal ulcers should
be carefully managed with appropriate coadministration
of PPIs [14,15].
Whether or not endoscopic examination is sensitive
enough to detect a previous gastric or duodenal ulcer
has not been thoroughly investigated. The aims of this
study were to determine the sensitivity of endoscopy
used as a tool for detecting ulcer scars and to determine
interobserver agreement in the endoscopic diagnosis of
ulcer scars.
Methods
Sensitivity of endoscopic study for detecting ulcer scars
From August 2010 to December 2010, 200 consecutive
patients with a past clinical history of gastric or duodenal
ulcer confirmed by esophagogastroduodenoscopy at least
12 months previously were enrolled at Shimane University
Hospital. Endoscopists, who were blinded to the past his-
tories of the patients, attempted to locate ulcer scars at
sites where active open ulcers had been previously
detected by endoscopy. Three well experienced endosco-
pists (YA, GU, and TY) participated in this study and eval-
uated endoscopic photographs separately. When their
diagnosis did not fit completely, they discussed and made
the final consensus diagnosis. Patients who had undergone
endoscopic surgery for gastroduodenal lesions, gastrect-
omy, or esophagectomy were not enrolled.
Interobserver agreement on endoscopic diagnosis
Forty-seven endoscopists participated in this study. The
median length of time they had worked as endoscopists
was 9.5 years. They were divided into groups based on
duration of experience and the presence or absence of
board certification from the Japan Gastroenterological
Endoscopy Society (JGES). Endoscopists can obtain JGES
board certification after completing 5 years of training in
endoscopy at a JGES-approved educational institution
and passing an examination administered by the JGES. In
the present study, “experienced” endoscopists were
defined as endoscopists who had been in practice for
over 10 years. “Expert” endoscopists were defined as
those with a JGES board certification. Twenty-two out of
47 were experienced and 29 were expert endoscopists.
The participating endoscopists diagnosed still endoscopic
photographs of 30 cases of previous gastric ulcers and 30
c a s e so fp r e v i o u sd u o d e n a lu l c e r sf o rt h ep r e s e n c eo r
absence of gastric or duodenal ulcer scars. All photo-
graphs showed the same gastroduodenal sites where
active peptic ulcers had been previously found (Figure 1).
In all the gastric ulcer cases, the sites of previous ulcers
were photographed with and without indigo carmine
staining, and each photograph was diagnosed separately.
There were 3 types of diagnosis: confident diagnosis of
ulcer scar, confident diagnosis of ulcer scar absence, and
equivocal.
Statistical analysis of interobserver agreement
The kappa coefficient of reliability was calculated to
measure interobserver agreement on the diagnosis of
ulcer scars. The assessments of a large number of obser-
vers with multiple objectives were analyzed using the
method proposed by Siegel and Castellan [16], as
described in previous reports [17,18]. Kappa coefficients
of reliability were determined plus 95% confidence inter-
vals (CIs). Complete disagreement between observers
would have a kappa value of -1 and perfect agreement a
kappa value of +1. A 0 value would mean agreement by
chance alone. A kappa value greater than 0.4 is generally
considered to be acceptable for 2-observer analysis.
However, the kappa coefficient of reliability tends to be
lower in analyses of a large number of observers. Kappa
Figure 1 Representative endoscopic images of the stomach where the active stage of peptic ulcer was found 12 months previously
with white light (A) and with chromoendoscopy using indigo-carmine dye (B). Representative endoscopic image of the duodenal cap
where the active stage of peptic ulcer was found 12 months previously (C).
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and statistical differences of kappa values between
groups were estimated.
The protocol of this study was prepared according to
the Declaration of Helsinki and the questionnaires
approved by the ethics committee of Shimane University
School of Medicine were used. Written informed con-
sent for the endoscopic study was obtained from all
participants.
Results
Sensitivity of endoscopic study to detect ulcer scars
Out of the 200 patients with a past history of endoscopi-
cally confirmed gastroduodenal ulcers, 10 patients were
found to have recurrent gastric and/or duodenal ulcers
and were excluded from analysis. Out of the remaining
190 patients, 104 were found to have ulcer scars on endo-
scopy. Ulcer scars were not identified in the remaining 86
cases, resulting in a sensitivity of 54.7% for the endo-
scopic diagnosis of the previous presence of ulcers, when
the examination focused on identifying ulcer scars.
Interobserver agreement on endoscopic diagnosis
A confident endoscopic diagnosis of ulcer scars was pos-
sible in 70% (95% CI 61.5%-77.2%) and 72% (95% CI
60.2%-81.9%) of patients with previous gastric and duo-
denal ulcers, respectively (Figure 2 and 3). The kappa
value of the endoscopic diagnosis on the presence or
absence of a gastric ulcer scar was 0.14 (95% CI 0.13-
0.16) in all the participating endoscopists (Figure 4). In
the experienced and the expert endoscopists, the kappa
values were 0.14 (95% CI 0.12-0.16) and 0.13 (95% CI
0.11-0.16), respectively. There were no significant differ-
ences found between experienced and inexperienced, or
expert and inexpert endoscopists. When endoscopists
diagnosed using indigo carmine chromoendoscopic
images of the same area, the kappa value of all participat-
ing endoscopists was 0.15 (95% CI 0.13-0.17), and there
was no statistically significant difference compared to
that without chromoendoscopy. Moreover, the kappa
values with chromoendoscopy of the experienced and
expert endoscopists were 0.14 (95% CI 0.12-0.16) and
0.16 (95% CI 0.13-0.18), respectively. They did not show
Figure 2 Endoscopic diagnostic concordance regarding presence or absence of gastric ulcer scar in 30 cases. (black box): confident
diagnosis of ulcer scar, (gray box): equivocal, (white box): confident diagnosis of ulcer scar absence.
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inexperienced: 0.14 (95% CI 0.12-0.15) and inexpert
endoscopists: 0.12 (95% CI 0.14-0.10).
Interobserver agreements on the endoscopic diagnosis
of duodenal ulcer scars are shown in Figure 5. The
kappa value for all the participating endoscopists on the
diagnosis of duodenal ulcer scars was 0.29 (95% CI 0.27-
0.32), which was significantly higher than the value of
gastric ulcers as shown in Figure 4. Experienced and
expert endoscopists showed higher kappa values, 0.31
(95% CI 0.29-0.35) and 0.31 (95% CI 0.29-0.35), than
inexperienced and inexpert endoscopists, 0.28 (95% CI
0.26-0.31) and 0.27 (95% CI 0.25-0.30), respectively,
although statistically significant differences were found.
Discussion
The confident endoscopic diagnosis of ulcer scars was
only possible in 54.7% of patients with previous gastro-
duodenal peptic ulcers, and the kappa value of the
endoscopic diagnosis on the presence or absence of gas-
troduodenal peptic ulcer scar was too low. Thus, in this
study, we demonstrated that endoscopic examination for
the detection of gastric and duodenal ulcer scars was
neither a sensitive nor reliable enough diagnostic modal-
ity for identifying a past history of peptic ulcers.
Recurrence of peptic ulcers caused by Helicobacter
pylori infection can be effectively prevented by Helico-
bacter pylori eradication therapy. Therefore, chronic
administration of NSAIDs and LDA are now the impor-
tant factors associated with ulcer recurrence [5-7].
Patients with a past history of peptic ulcers are consid-
ered to have the highest risk for ulcer recurrence and
complications when exposed to chronic NSAIDs or
LDA administration [8,10]. Therefore, prophylactic
administration of PPIs is recommended for chronic
NSAIDs or LDA users who have a previous history of
peptic ulcer. Diagnosing a past history of ulcer disease
can be accomplished by 2 different methods. First,
obtaining an accurate patient history of gastroduodenal
ulcer disease is considered to be a good approach. How-
ever, in daily practice, not all patients with a previous
gastric or duodenal ulcer can be accurately identified as
having a history of ulcer disease. Abdominal symptoms
do not occur in every patient with an ulcer, and as high
Figure 3 Endoscopic diagnostic concordance regarding presence or absence of duodenal ulcer scar in 30 cases. (black box): confident
diagnosis of ulcer scar, (gray box): equivocal, (white box): confident diagnosis of ulcer scar absence.
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abdominal complaints, even in the presence of endosco-
pically identified active ulcers [19]. Therefore, obtaining
a medical history from the patient is not sensitive
enough for appropriate prophylaxis of NSAIDs- and
LDA-related ulcer recurrence.
A second possible method for the diagnosis of pre-
vious peptic ulcer disease is endoscopic identification of
ulcer scars. Ulcer scars found in the stomach and duo-
denum are characterized by whitish or reddish color
changes, smooth converging folds, deformity of the gas-
tric or duodenal wall, presence of regenerating epithe-
lium, and presence of a linear depression [20-22].
Theoretically, therefore, the endoscopic identification of
a gastroduodenal scar should not be difficult. In this
study, we examined whether the diagnosis of previous
ulcer disease by endoscopic identification of ulcer scars
was easy and feasible. Contrary to our initial assump-
tion, the diagnostic sensitivity of endoscopy for ulcer
scars was only 55%, and diagnostic concordance among
endoscopists was far below the acceptable level even if
the chromoendoscopy with indigo carmine was added.
We previously demonstrated a low diagnostic concor-
dance among endoscopists using endoscopy to identify
low-grade reflux esophagitis and short-segment Barrett’s
esophagus [17,18]. In evaluating endoscopy as a diagnos-
tic modality for previous ulcer disease, we again have
discovered problems in the diagnostic reliability of ulcer
scars. Since neither endoscopy nor obtaining a medical
history from the patient are sensitive enough by them-
selves to discover previous ulcer disease, at present we
must use both methods to compensate each other, espe-
cially in patients who need chronic NSAIDs or LDA
therapy.
There are limitations to this study. The endoscopic
images were still photographs, but not dynamic observa-
tion. Therefore, the results of the present study need to
be confirmed by video endoscopy. JSGE and other medi-
cal institutions have rarely offered training in the endo-
scopic identification of ulcer scars. Proper training and
education may improve diagnostic sensitivity and con-
cordance, and its effects should be evaluated in future.
Figure 4 Kappa values for the endoscopic diagnosis of gastric ulcer scars by white light endoscopy (black circle) and by
chromoendoscopy using indigo carmine dye (white circle). Bars depict 95% confidence intervals.
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We have demonstrated that the sensitivity and concor-
dance of endoscopic diagnosis of gastric and duodenal
ulcer scars are not satisfactory for the use of endoscopy as
a sole diagnostic modality for previous ulcer disease. To
avoid the overlooking the previous clinical history of pep-
tic ulcer diseases, the diagnosis of peptic ulcer scar has to
be carefully done prior to NSAIDs administration.
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